A5078955406- Pharmaceutical Practices and Patient Outcomes
- Patient Safety and Medication Errors
- Public Health in Brazil
- Malaria Research and Control
- Medication Adherence and Compliance
- Drug Transport and Resistance Mechanisms
- Hibiscus Plant Research Studies
- Chemical Reaction Mechanisms
- Nursing Diagnosis and Documentation
- Pregnancy and preeclampsia studies
- Pharmaceutical studies and practices
- Lysosomal Storage Disorders Research
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Regulation
- Cardiac, Anesthesia and Surgical Outcomes
- Estrogen and related hormone effects
- Respiratory and Cough-Related Research
- Phytochemical Studies and Bioactivities
- Blood Pressure and Hypertension Studies
- Pharmacological Effects and Toxicity Studies
- Maternal Mental Health During Pregnancy and Postpartum
- Phytochemical and Pharmacological Studies
- Pregnancy and Medication Impact
- Cellular transport and secretion
- Cardiovascular Syncope and Autonomic Disorders
Universidade Federal do Paraná
2009-2022
To measure length of hospital stay (LHS) in patients receiving medication reconciliation. Secondary characteristics included analysis number preadmission medications, medications prescribed at admission, discrepancies, and pharmacists interventions done accepted by the attending physician.A 6 month, randomized, controlled trial conducted a public teaching southern Brazil. Patients admitted to general wards were randomized receive usual care or reconciliation, performed within first 72 hours...
this observational study aimed to describe the discrepancies identified during medication reconciliation on patient admission cardiology units in a large hospital.the history of patients was collected within 48 hours after admission, and intentional unintentional were classified as omission, duplication, dose, frequency, timing, route drug administration.most evaluated women (58.0%) with mean age 59 years, 75.5% had Charlson comorbidity index score between 1 3. Of 117 found, 50.4%...
Artemisinins combination therapy (ACT) is the first choice for falciparum malaria. Data on safety of ACTs in pregnancy are limited and controversial use not recommended trimester. To evaluate effects isolated combined artesunate (AS)/mefloquine (MQ) embryo rats, pregnant rats were treated orally with AS (15 40 mg/kg body weight (bwt)/day), MQ (30 80 bwt/day) AS/MQ (15/30 40/80 days 9–11 post coitum (pc). The dams euthanized day 12 pc gestational embryos histological parameters evaluated....